CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 100 enrolled
Drug / intervention
Tranexamic acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01085006
NCT01085006Phase 2Completed
CompareCT.gov

The Effect of Tranexamic Acid Administration on Postpartum Hemorrhage During and After Cesarean Delivery

Tehran University of Medical Sciences·interventional·Posted Mar 11, 2010·Updated Jan 25, 2011

In Brief

A Phase 2 clinical trial evaluating Tranexamic acid and Normal saline for Hemorrhage. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Intravenous Tranexamic acid is used to reduce the hemorrhage during and after cesarean delivery in a double blind randomized placebo controlled trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage
CountriesIran
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 11, 2010
Enrollment StartSep 1, 2009
Primary CompletionAug 1, 2010
Study CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 16.3 years ago

Interventions

Tranexamic aciddrug

Tranexamic acid in cases, normal saline in controls

Normal salinedrug

Tranexamic acid in cases, normal saline in controls